Skip to main content
. 2018 Jul 3;9:528. doi: 10.3389/fneur.2018.00528

Table 1.

Demographics of patients with acute multifocal embolic infarcts.

Af alone TS group p-value
(n = 35) (n = 38)
Age, years (mean ± SE) 74.7 ± 1.53 75.2 ± 1.66 n.s.
Male sex, n (%) 24 (74%) 23 (61%) n.s.
NIHSS 4.74 ± 0.92 3.76 ± 0.44 n.s.
Body mass index (mean ± SE) 21.3 ± 0.59 21.2 ± 0.67 n.s.
Risk factors
    Hypertension 17 (49%) 17 (45%) n.s.
    Diabetes 11 (31%) 9 (24%) n.s.
    Hyperlipidemia 8 (23%) 10 (26%) n.s.
    Smoking* 13 (42%) 12 (35%) n.s.
Preventive therapy for infarction
    Anticoagulant therapy 8 (23%) 2 (5%) <0.05
    Antiplatelet therapy 2 (6%) 5 (14%) n.s.
Anticoagulant therapy after stroke 31 (89%) 31 (82%) n.s.
Maximum size of lesion < 15 mm 23 (66%) 20 (53%) n.s.
Infarcts on multiple vascular territories 17 (49%) 28 (74%) <0.05
D-dimer value (μg/mL)
    On admission 1.14 ± 0.14 8.45 ± 1.79 <0.0001
    During days 7–28 0.48 ± 0.12 11.20 ± 2.77 <0.0001

Af, atrial fibrillation; others, other diseases; SE, standard error; n.s., not significant.

*

Smoking histories of nine patients (five with Af, four with cancer) could not be determined.

D-dimer values between days 7 and 28 after stroke onset in 28 patients (11 with Af, 17 with cancer) could not be determined.